(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP
15-4310 / 25mg
CAS:1360823-43-3
(+)-1,13-Bis(diphenyl)phosphino-(5aR,8aR,14aR)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (R,R,R)-(+)-Ph-SKP
15-4310 / 100mg
CAS:1360823-43-3
(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP
15-4311 / 25mg
CAS:1439556-82-7
(-)-1,13-Bis(diphenyl)phosphino-(5aS,8aS,14aS)-5a,6,7,8,8a,9-hexahydro-5H-[1]benzopyrano [3,2-d]xanthene, 97% (S,S,S)-(-)-Ph-SKP
15-4311 / 100mg
CAS:1439556-82-7
2-[(1,1-Dimethylethyl)thio]-N-[2-(diphenylphosphino)ethyl]-ethanamine
15-4665 / 50mg
CAS:1883429-96-6
(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu
15-5131 / 25mg
CAS:912457-08-0
(11aS)-(-)-10,11,12,13-Tetrahydro-5-(1,1-dimethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (S)-FuP-tBu
15-5131 / 100mg
CAS:912457-08-0
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS
15-5150 / 100mg
CAS:443965-14-8
(11aR)-(+)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (R)-SIPHOS
15-5150 / 500mg
CAS:443965-14-8
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS
15-5151 / 500mg
CAS:443965-10-4
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-dimethylamine, min. 98% (S)-SIPHOS
15-5151 / 100mg
CAS:443965-10-4
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP
15-5157 / 500mg
CAS:885701-71-3
(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-phenoxy, min. 98% (S)-ShiP
15-5157 / 100mg
CAS:885701-71-3